文献速递腹部CTMR

LI-RADS对MRI和CT检测肝细胞癌的诊断效能:系统评价与诊断性Meta分析

Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis.
PubMed 文献 · Eur J Radiol · 2020-12-01

该系统评价与诊断性Meta分析纳入18项研究共3386例患者,评估LI-RADS≥3(LI-RADS 3-5v)诊断肝细胞癌的效能,汇总敏感度0.86、特异度0.85、AUC 0.92;MRI敏感度高于CT(0.82 vs 0.73),≤30 mm的肝细胞癌敏感度降至0.72;LR-5和LR≥5特异度更高,但敏感度降低;作者结论认为需进一步前瞻性研究阐明LI-RADS≥3对小肝癌(≤20 mm)的诊断价值。

要点

  • LI-RADS≥3诊断肝细胞癌的汇总敏感度0.86、特异度0.85、AUC 0.92。
  • MRI敏感度高于CT(0.82 vs 0.73),两者特异度相当(0.79 vs 0.78)。
  • ≤30 mm的肝细胞癌LI-RADS敏感度较低,为0.72,特异度0.80。

诊断标准与关键数值

  • LI-RADS≥3(LI-RADS 3-5v)诊断肝细胞癌的汇总敏感度0.86(95%CI 0.78-0.91),特异度0.85(95%CI 0.78-0.90),AUC 0.92(95%CI 0.89-0.94)。
  • MRI诊断肝细胞癌的敏感度0.82、特异度0.79;CT敏感度0.73、特异度0.78;MRI敏感度高于CT(0.82 vs 0.73),特异度相当(0.79 vs 0.78)。
  • ≤30 mm的肝细胞癌LI-RADS敏感度0.72、特异度0.80,低于所有大小肝细胞癌的汇总值。
  • LR-5与LR-3比较:敏感度0.67 vs 0.07(P=0.02),特异度0.93 vs 0.75(P<0.001);LR-5与LR-4比较:敏感度0.67 vs 0.29(P=0.02),特异度0.93 vs 0.80(P=0.75)。
  • LR≥5与LR≥3比较:特异度0.94 vs 0.68(P<0.001),敏感度0.66 vs 0.74(P=0.70);LR≥5与LR≥4比较:特异度0.94 vs 0.84(P<0.001),敏感度0.66 vs 0.74(P=0.77)。

临床应用与阅片要点

  • 作者结论认为LI-RADS≥3对肝细胞癌诊断准确度高,LR-5和LR≥5特异度更高,但敏感度降低。
  • 作者指出需进一步前瞻性研究阐明LI-RADS≥3对小肝癌(≤20 mm)的诊断价值。

局限性

  • 原文结论指出需进一步前瞻性研究阐明LI-RADS≥3对小肝癌(≤20 mm)的诊断价值。
  • Meta回归分析显示发表年份、对参考标准设盲和阅片者数量是影响异质性的显著因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To perform a meta-analysis evaluating the diagnostic accuracy of the Liver Imaging Reporting and Data System (LI-RADS) category ≥ 3 (LI-RADS 3-5v) for detecting hepatocellular carcinoma (HCC).

METHOD: A systematic PubMed, Embase, and Web of Science electronic database search was performed for original diagnostic studies published through July 31, 2018. Statistical analysis included data pooling, forest plot construction, heterogeneity testing, meta-regression, and subgroup analyses.

RESULTS: Eighteen studies (v2011, v2014 and v2017) involving 3386 patients were included in the meta-analysis. The pooled sensitivity and specificity of LI-RADS ≥ 3 for diagnosing HCC were 0.86 (95 % confidence interval (CI): 0.78-0.91) and 0.85 (95 % CI: 0.78-0.90), respectively. The area under the curve (AUC) was 0.92 (95 % CI: 0.89-0.94). Meta-regression analysis showed that the publication year, blinding to the reference standard and the number of readers were significant factors affecting heterogeneity. In subgroup analyses, magnetic resonance imaging (MRI) demonstrated higher sensitivity (0.82 vs. 0.73) and comparable specificity (0.79 vs. 0.78) than computed tomography (CT). For HCCs ≤30 mm, LI-RADS showed lower sensitivity of 0.72 and specificity of 0.80 compared with HCC of all sizes. LR-5 showed higher sensitivity and specificity than LR-3 (sensitivity: 0.67 vs. 0.07, P = 0.02; specificity: 0.93 vs. 0.75, p < 0.001) and higher sensitivity than LR-4 (sensitivity: 0.67 vs. 0.29, P = 0.02; specificity: 0.93 vs. 0.80, p = 0.75). LR ≥ 5 had higher specificity at the cost of decreased sensitivity than LR ≥ 3 (specificity: 0.94 vs. 0.68, p < 0.001; sensitivity: 0.66 vs. 0.74, P = 0.70) and LR ≥ 4 (specificity: 0.94 vs. 0.84, p < 0.001; sensitivity: 0.66 vs. 0.74, P = 0.77).

CONCLUSIONS: LI-RADS ≥ 3 shows high diagnostic accuracy for HCCs, with a pooled sensitivity of 0.86 and specificity of 0.85. The specificity is higher for LR-5 and LR ≥ 5. However, further prospective studies on LI-RADS ≥ 3 are needed to elucidate its value for diagnosing small HCCs (≤20 mm).

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Liang Y, Xu F, Guo Y, et al. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis. Eur J Radiol. 2020. PMID: 33276248. doi:10.1016/j.ejrad.2020.109404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。